Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Keyphrases
Radiotherapy
75%
Thyroid Tumor
50%
Lanthanide Ions
50%
Radiation-protective Agents
50%
Radioresistance
50%
Radio Optimization
50%
Translational Approach
50%
Nanoparticles
50%
Glioma Tumor
50%
Radiosensitivity
50%
Glioblastoma
50%
Nanoplatform
50%
In Vitro Model
50%
Carbon Dots (C-dots)
50%
Metabolite Profile
50%
Non-targeted Analysis
50%
Glioma Diagnosis
50%
Survival Curve
37%
Tumor
25%
IDH-mutant Glioma
20%
Hough
16%
Enumeration Techniques
16%
Precise Detection
16%
Software Effectiveness
16%
Manual Editing
16%
ImageJ Software
16%
Tumor Tissue
12%
Differentiated Thyroid Cancer
12%
Mass Spectrometry
12%
Metabolomics
12%
Liquid Nitrogen
12%
Radiation Dose
12%
Volume Ratio
12%
Metabolomic Strategy
12%
Atomic number
12%
Gd3+
12%
DeepL
12%
Radiotherapy Treatment
12%
Yb3+
12%
Nanotechnology
12%
Metabolic Footprint
12%
Geant4
12%
Brain Tumor
12%
Tissue Sampling
12%
Material Size
12%
Metabolomics Study
12%
Radiosensitization
12%
Metabolic
12%
Expression Profile
12%
Physical Parameters
12%
Patient Response
12%
Physical Simulation
12%
Translator
12%
Cancer Types
12%
Healthy Tissue
12%
X-ray
12%
Glial Cells
12%
High Dose
12%
Central Nervous System
12%
Nanomaterials
12%
In Vitro Test
12%
Radioresistant Tumor
12%
Inpatient Treatment
12%
Resistant to Treatment
12%
Biological Heterogeneity
10%
Endocrine Neoplasia
10%
WHO Grade 4
10%
Diagnostic Workflow
10%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Radiosensitizing Agent
62%
Carbon Quantum Dot
50%
Lanthanide
50%
Glioblastoma
50%
Thyroid Tumor
50%
Nanoparticle
50%
Recurrent Disease
50%
Pathogenesis
50%
Glioma
50%
Differentiated Thyroid Cancer
42%
Recurrence Risk
20%
Malignant Neoplasm
12%
Liquid Nitrogen
12%
Intracranial Tumor
12%
Nanomaterial
12%
Side Effect
12%
Carboxylate
10%
Pyridine Derivative
10%
Purine
10%
Oxoacid
10%
Hydroxyacid
10%
Phosphoric Acid
10%
Purine Derivative
10%
Fatty Acid
10%
Amino Acid
10%
Medicine and Dentistry
Ganglioglioma
50%
Molecular Profiling
50%
Targeted Metabolomics
50%
Glioblastoma
33%
Molecular Diagnosis
25%
Oligoastrocytoma
16%
Biological Marker
16%
Promoter Region
16%
Methylation
16%
Multiplex Ligation Dependent Probe Amplification
16%
Carboxylic Acid
10%
Oxoacid
10%
Pyridine Derivative
10%
Phosphoric Acid
10%
Hydroxyacid
10%
Brain Cancer
8%
Oligodendroglioma
8%
Cyclin Dependent Kinase Inhibitor 2A
8%
Molecular Classification
8%
Tumor
8%
Epidermal Growth Factor Receptor
8%
Sanger Sequencing
8%
Pathogenesis
8%